Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-24

Clinical Trial Update: Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial entry describes an ongoing Phase 2/Phase 3 study evaluating electroacupuncture plus immune checkpoint inhibitors as adjuvant therapy after s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kong Fanming | Conditions: Non-Small Cell Lung Cancer, Electroacupuncture | Phase 2, Phase 3 | Status: RECRUITING